Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Topical Delivery of Niacinamide: Influence of Binary and Ternary Solvent Systems.

Zhang Y, Kung CP, Sil BC, Lane ME, Hadgraft J, Heinrich M, Sinko B.

Pharmaceutics. 2019 Dec 10;11(12). pii: E668. doi: 10.3390/pharmaceutics11120668.

2.

Preparation, Characterisation, and Topical Delivery of Terbinafine.

Hossain ASMMA, Sil BC, Iliopoulos F, Lever R, Hadgraft J, Lane ME.

Pharmaceutics. 2019 Oct 22;11(10). pii: E548. doi: 10.3390/pharmaceutics11100548.

3.

Preparation, Characterization and Dermal Delivery of Methadone.

Kung CP, Sil BC, Hadgraft J, Lane ME, Patel B, McCulloch R.

Pharmaceutics. 2019 Oct 2;11(10). pii: E509. doi: 10.3390/pharmaceutics11100509.

4.

A Preliminary Investigation of Additive Manufacture to Fabricate Human Nail Plate Surrogates for Pharmaceutical Testing.

Sil BC, Patel A, Crowther JM, Moore DJ, Hadgraft J, Hilton ST, Lane ME.

Pharmaceutics. 2019 May 28;11(6). pii: E250. doi: 10.3390/pharmaceutics11060250.

5.

A comparison of the in vitro permeation of niacinamide in mammalian skin and in the Parallel Artificial Membrane Permeation Assay (PAMPA) model.

Zhang Y, Lane ME, Hadgraft J, Heinrich M, Chen T, Lian G, Sinko B.

Int J Pharm. 2019 Feb 10;556:142-149. doi: 10.1016/j.ijpharm.2018.11.065. Epub 2018 Dec 6.

PMID:
30529662
6.

Monitoring Drug Crystallization in Percutaneous Penetration Using Localized Nanothermal Analysis and Photothermal Microspectroscopy.

Goh CF, Moffat JG, Craig DQM, Hadgraft J, Lane ME.

Mol Pharm. 2019 Jan 7;16(1):359-370. doi: 10.1021/acs.molpharmaceut.8b01027. Epub 2018 Dec 20.

PMID:
30525649
7.

Topical delivery of climbazole to mammalian skin.

Paz-Alvarez M, Pudney PDA, Hadgraft J, Lane ME.

Int J Pharm. 2018 Oct 5;549(1-2):317-324. doi: 10.1016/j.ijpharm.2018.07.058. Epub 2018 Jul 25.

8.

Topical delivery of anthramycin II. Influence of binary and ternary solvent systems.

Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME.

Eur J Pharm Sci. 2018 Aug 30;121:59-64. doi: 10.1016/j.ejps.2018.05.002. Epub 2018 May 7.

PMID:
29746912
9.

Topical delivery of anthramycin I. Influence of neat solvents.

Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME.

Eur J Pharm Sci. 2017 Jun 15;104:188-195. doi: 10.1016/j.ejps.2017.03.043. Epub 2017 Mar 31.

PMID:
28373034
10.

The application of ATR-FTIR spectroscopy and multivariate data analysis to study drug crystallisation in the stratum corneum.

Goh CF, Craig DQ, Hadgraft J, Lane ME.

Eur J Pharm Biopharm. 2017 Feb;111:16-25. doi: 10.1016/j.ejpb.2016.10.025. Epub 2016 Nov 11.

PMID:
27845181
11.

Advanced topical formulations (ATF).

Hadgraft J, Lane ME.

Int J Pharm. 2016 Nov 30;514(1):52-57. doi: 10.1016/j.ijpharm.2016.05.065. Epub 2016 May 31. Review.

PMID:
27260130
12.

Topical delivery of hexamidine.

Parisi N, Paz-Alvarez M, Matts PJ, Lever R, Hadgraft J, Lane ME.

Int J Pharm. 2016 Jun 15;506(1-2):332-9. doi: 10.1016/j.ijpharm.2016.04.069. Epub 2016 Apr 26.

PMID:
27130367
13.

A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.

Luo L, Patel A, Sinko B, Bell M, Wibawa J, Hadgraft J, Lane ME.

Int J Pharm. 2016 May 30;505(1-2):14-9. doi: 10.1016/j.ijpharm.2016.03.043. Epub 2016 Mar 26.

PMID:
27025294
14.

Drug crystallization - implications for topical and transdermal delivery.

Hadgraft J, Lane ME.

Expert Opin Drug Deliv. 2016 Jun;13(6):817-30. doi: 10.1517/17425247.2016.1140146. Epub 2016 Feb 3. Review.

PMID:
26766744
15.

Preparation and characterisation of hexamidine salts.

Parisi N, Matts PJ, Lever R, Hadgraft J, Lane ME.

Int J Pharm. 2015 Sep 30;493(1-2):404-11. doi: 10.1016/j.ijpharm.2015.07.071. Epub 2015 Jul 30.

PMID:
26235920
16.

Preparation, characterization and buccal permeation of naratriptan.

Sattar M, Hadgraft J, Lane ME.

Int J Pharm. 2015 Sep 30;493(1-2):146-51. doi: 10.1016/j.ijpharm.2015.07.035. Epub 2015 Jul 18.

PMID:
26196276
17.

Topical therapies for skin cancer and actinic keratosis.

Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME.

Eur J Pharm Sci. 2015 Sep 18;77:279-89. doi: 10.1016/j.ejps.2015.06.013. Epub 2015 Jun 16. Review.

PMID:
26091570
18.

Transdermal delivery of testosterone.

Hadgraft J, Lane ME.

Eur J Pharm Biopharm. 2015 May;92:42-8. doi: 10.1016/j.ejpb.2015.02.015. Epub 2015 Feb 20. Review.

PMID:
25709060
19.

Influence of lidocaine hydrochloride and penetration enhancers on the barrier function of human skin.

Hirata K, Mohammed D, Hadgraft J, Lane ME.

Int J Pharm. 2014 Dec 30;477(1-2):416-20. doi: 10.1016/j.ijpharm.2014.10.012. Epub 2014 Oct 8.

PMID:
25305378
20.

Percutaneous absorption of salicylic acid--in vitro and in vivo studies.

Mateus R, Moore DJ, Hadgraft J, Lane ME.

Int J Pharm. 2014 Nov 20;475(1-2):471-4. doi: 10.1016/j.ijpharm.2014.08.061. Epub 2014 Aug 29.

PMID:
25178827

Supplemental Content

Loading ...
Support Center